Nowadays, there's lots of buzz about spectacular new medical treatments such as personalised cancer therapy with modified immune cells or antibodies. Such treatments, however, are very complex and ...

CHENGDU, China--(BUSINESS WIRE)--HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today. This whitepaper will provide the ...

DNA-Encoded Library (DEL) technology has transformed early-stage drug discovery by enabling the simultaneous synthesis and screening of millions to billions of small molecules in a single pooled ...

MADISON, Wis.--(BUSINESS WIRE)--A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery.

The discovery of high-affinity ligands is crucial for virtually any drug discovery campaign. The pharmaceutical industry relies on vast collections of individual compounds (typically 0.5 to 4 million) ...

DNA-encoded library (DEL) technology is a promising new tool for identifying ligands for challenging protein targets, allowing for the preparation and screening of large chemical libraries with ...

Over the past few decades, material scientists and chemists have been working on designing increasingly sophisticated materials for a wide range of technological and scientific applications. These ...

Philochem AG has discovered an ultra-high-affinity ACP3 ligand – OncoACP3 – isolated through the screening of DNA-encoded chemical libraries for the potential treatment of prostate cancer.